文献速递儿童消化与营养儿童感染

临床路径持续改善急性胃肠炎诊疗

Clinical Pathway Produces Sustained Improvement in Acute Gastroenteritis Care.
PubMed 文献 · Pediatrics · 2017-09-07

结果显示,路径实施后接受静脉补液的患者比例从48%降至26%,离院患者急诊停留时间从247分钟降至172分钟,且改善持续10年。

要点

  • 临床路径强调口服补液和昂丹司琼,可减少急性胃肠炎患儿静脉补液使用。
  • 路径实施后离院患者急诊停留时间缩短,且改善持续10年。
  • 质量改进干预对急性胃肠炎诊疗具有长期影响。

核心结论

  • 实施强调口服补液疗法和昂丹司琼的临床路径,可减少儿科急诊急性胃肠炎患儿的静脉补液使用并缩短离院患者急诊停留时间。
  • 上述改善在10年期间持续存在。

研究设计与样本

  • 研究为质量改进项目,在儿科急诊实施急性胃肠炎临床路径。
  • 通过国际疾病分类第九版临床修订版诊断代码识别病例,采用统计过程控制分析路径实施前2年及后10年的过程和结局指标。

主要发现

  • 路径启动后接受静脉补液的患者比例出现向下偏移的特殊原因变异,后续将昂丹司琼加入路径后该比例从48%降至26%。
  • 急性胃肠炎离院患者的平均急诊停留时间从247分钟降至172分钟。
  • 上述改善随时间持续存在。

关键数值与推荐

  • 接受静脉补液的患者比例从48%降至26%。
  • 离院患者平均急诊停留时间从247分钟降至172分钟。

临床怎么用

  • 儿科急诊可实施以口服补液疗法和昂丹司琼为核心的急性胃肠炎临床路径,以减少静脉补液使用并缩短离院患者急诊停留时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Despite widespread use of the rotavirus vaccine in the last decade, dehydrating illnesses impact almost 2 billion children worldwide annually. Evidence supports oral rehydration therapy as a first-line treatment of mild to moderate dehydration. Ondansetron has proven to be a safe and effective adjunct in children with vomiting. We implemented a clinical pathway in our pediatric emergency department (ED) in January 2005 to improve care for this common condition. Our objective in this study was to determine the long-term impact of the pathway for acute gastroenteritis (AGE) on the proportion of patients receiving intravenous (IV) fluids and ED length of stay (LOS) for discharged patients. METHODS: Cases were identified by using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. We used statistical process control to analyze process and outcome measures for 2 years before and 10 years after pathway implementation. RESULTS: We included 30 519 patients. We found special cause variation with a downward shift in patients receiving IV fluids after initiation of the pathway and later with addition of ondansetron to the pathway from 48% to 26%. Mean ED LOS for discharged patients with AGE decreased from 247 to 172 minutes. These improvements were sustained over time. CONCLUSIONS: Implementation of a clinical pathway emphasizing oral rehydration therapy and ondansetron for children with AGE led to decreased IV fluid use and LOS in a pediatric ED. Improvements were sustained over a 10-year period. Our results suggest that quality-improvement interventions for AGE can have long-term impacts on care delivery.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Rutman L, Klein EJ, Brown JC, et al. Clinical Pathway Produces Sustained Improvement in Acute Gastroenteritis Care. Pediatrics. 2017. PMID: 28882877. doi:10.1542/peds.2016-4310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。